Elevating your Regenerative
Treatments

exosmart™ is an advanced autologous exosome and regenerative technology available to healthcare professionals in Australia through BioTrace Medical Solutions.

Using advanced ultrafiltration technology, exosmart concentrates extracellular vesicles, platelets, growth factors and other regenerative components from a patient's own plasma to create a personalised autologous preparation for clinical use.

ARTG Registered     •      CE-MDR Certified     •     Made in Italy     •     Designed for Medical Professionals

What is exosmart?

exosmart is designed to help clinicians prepare a concentrated autologous product from the patient’s own plasma. The system captures exosomes, platelets and growth factors into a smaller final volume, creating a personalised preparation for regenerative aesthetic and clinical applications.

Autologous Exosome Technology

Unlike donor-derived exosome products, autologous exosomes originate from the patient's own biological material. exosmart uses advanced ultrafiltration technology to concentrate extracellular vesicles and other regenerative components from the patient's own plasma.

This approach provides Australian healthcare professionals with an innovative regenerative solution designed to complement modern regenerative medicine workflows.

How the ultrafiltration technology works

1. Blood draw

Patient’s own blood is collected.

2. Plasma preparation + exosmart concentration

The plasma is processed through the exosmart ultrafiltration system.

3. Exosome-rich concentrate

The clinician receives a concentrated autologous preparation for immediate clinical use.

Why Clinics Are Looking Beyond Conventional PRP

Clinical Application Areas

The exosmart system uses advanced technology to concentrate a patient’s own natural growth factors and exosomes to help stimulate tissue repair. Please note that these represent specialized areas of clinical application for medical professionals, rather than guaranteed consumer results. Because it works by supporting the body’s natural healing signals, this versatile therapy is utilized across several key fields:

Treatment Gallery

*Results may vary due to many factors including the individual’s genetics, diet and exercise.

Exosomes Australia – Understanding Autologous Exosome Technology

Interest in exosomes in Australia continues to grow as healthcare professionals explore emerging technologies within regenerative medicine.

BioTrace Medical Solutions provides Australian healthcare professionals with access to exosmart, an advanced autologous plasma processing technology designed to concentrate extracellular vesicles, platelet-derived secretome components and plasma proteins from the patient's own blood.

ABOUT EXOSMART™

What is exosmart?

exosmart is an advanced autologous plasma processing system designed to concentrate extracellular vesicles (EVs), platelet-derived secretome components and plasma proteins from a patient’s own blood. Using a proprietary ultrafiltration process, exosmart provides clinicians with a concentrated regenerative biologic prepared entirely from the patient’s own plasma.

Why choose exosmart?

exosmart combines advanced ultrafiltration technology with an efficient clinical workflow to provide a reproducible method of preparing an autologous regenerative biologic. Supported by clinician education, ongoing training and local Australian support from BioTrace Medical Solutions, exosmart offers practices a streamlined approach to integrating regenerative medicine into everyday clinical care.

How is exosmart different from PRP?

Traditional PRP focuses primarily on concentrating platelets. exosmart uses a different processing approach, concentrating extracellular vesicles together with platelet-derived secretome components and plasma proteins from platelet-rich plasma. This provides clinicians with an additional regenerative biologic option using the patient’s own blood.

Is exosmart autologous?

Yes. exosmart is a fully autologous system. The final concentrate is prepared exclusively from the patient’s own blood, with no donor-derived or synthetic biological materials added.

How long does the process take?

From blood collection to the final concentrate, the exosmart workflow is designed to integrate efficiently into clinical practice and is typically completed in approximately 30–40 minutes, depending on the clinic’s workflow.

What applications can it support?

exosmart is intended to prepare an autologous regenerative biologic for use by appropriately qualified healthcare professionals. Clinicians may choose to incorporate exosmart into a range of regenerative medicine workflows based on their own clinical judgement, applicable regulations and individual patient needs.

Why is extracellular vesicle concentration important?

Extracellular vesicles are naturally occurring biological messengers released by cells. They carry proteins, lipids and genetic material involved in cell-to-cell communication. exosmart is designed to concentrate extracellular vesicles together with other plasma-derived regenerative components from the patient’s own blood using its proprietary filtration process.

Who can use exosmart?

exosmart is designed for use by qualified healthcare professionals trained in blood collection, plasma preparation and regenerative medicine procedures, including doctors, specialists and other appropriately licensed clinicians.

EXOSOMES & REGENERATIVE TECHNOLOGY

What are autologous exosomes?

Autologous exosomes are extracellular vesicles derived from a patient’s own biological material. They are involved in cell-to-cell communication and carry biological signals including proteins and other molecules.

Technologies such as exosmart™ use a patient’s own plasma to concentrate extracellular vesicles and other regenerative components, providing an autologous approach for healthcare professionals exploring advanced regenerative technologies.

Are autologous exosomes available in Australia?

Yes. exosmart™ is available in Australia through BioTrace Medical Solutions for healthcare professionals and clinics interested in autologous regenerative technology.

Unlike donor-derived exosome products, exosmart uses the patient’s own blood as the starting material, creating an autologous preparation at the point of care.

For information about exosmart in Australia, including product information, training and demonstrations, contact BioTrace Medical Solutions.

What is exosmart™ Australia?

exosmart™ is an advanced plasma processing and ultrafiltration technology available to healthcare professionals in Australia through BioTrace Medical Solutions.

The system is designed to concentrate extracellular vesicles, platelets, growth factors and other regenerative components from a patient’s own plasma.

Because the preparation originates from the patient’s own blood, exosmart provides an autologous regenerative solution for healthcare professionals exploring emerging technologies in regenerative medicine.

How does exosmart™ concentrate exosomes?

exosmart™ uses advanced ultrafiltration technology to process a patient’s plasma and concentrate extracellular vesicles and other biologically active components.

The filtration process reduces excess plasma volume while retaining selected regenerative components, creating a concentrated autologous preparation from the patient’s own biological material.

What is the difference between exosmart™ and PRP?

PRP (Platelet-Rich Plasma) is primarily designed to concentrate platelets from a patient’s blood.

exosmart™ uses advanced ultrafiltration technology to further process plasma and concentrate extracellular vesicles alongside platelets, growth factors and other regenerative components.

Both approaches use the patient’s own blood, but the processing methods and resulting preparations are different.

Healthcare professionals should determine the appropriate technology based on the intended clinical application and applicable Australian regulatory requirements.

What are exosomes and how are they related to regenerative medicine?

Exosomes are small extracellular vesicles released by cells that play an important role in cell-to-cell communication. They can transport proteins, lipids and other biological signals between cells.

Because of their role in cellular communication, exosomes and extracellular vesicles are an area of significant scientific interest within regenerative medicine and regenerative technology.

BioTrace Medical Solutions provides healthcare professionals with access to emerging regenerative technologies, including exosmart™ autologous plasma processing technology.

What is regenerative technology?

Regenerative technology refers to technologies and medical approaches designed to work with or utilise the body’s own biological processes.

This may include technologies involving blood-derived components, platelets, growth factors, extracellular vesicles and other biological signalling mechanisms.

BioTrace Medical Solutions specialises in bringing advanced regenerative technologies and regenerative solutions to healthcare professionals across Australia.

Where can Australian clinics access exosmart™?

Australian healthcare professionals and clinics interested in exosmart™ can contact BioTrace Medical Solutions, the Australian provider of the technology.

BioTrace provides product information, education, training and support to healthcare professionals interested in incorporating advanced regenerative technology into their clinical practice.

Contact our team to discuss exosmart™, request further information or arrange a demonstration.

TRAINING, AVAILABILITY & SUPPORT

INTERESTED IN EXOSMART?

Discover What Advanced Ultrafiltration Can Bring to Your Practice

Learn more about exosmart technology, clinical applications, practitioner training and how it can be integrated into your existing treatment offering.

Image

Innovation

Advancing care through smarter medical solutions.

Image

Integrity

Trusted partnerships built on transparency.

Excellence

Excellence

Quality without compromise.

FOLLOW US

COMPANY

CUSTOMER CARE

Copyright 2026. All Rights Reserved.